Induction of BRCAness in Triple-Negative Breast Cancer by a CDK12/13 Inhibitor Improves Chemotherapy

被引：19
|
作者：
Hopkins, Jessica L. [1 ]
Zou, Lee [1 ,2 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Charlestown, MA 02129 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
来源：
CANCER CELL | 2019年 / 36卷 / 05期
关键词：
D O I：
10.1016/j.ccell.2019.10.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this issue of Cancer Cell, Quereda and colleagues report that a newly developed specific inhibitor of CDK12/13, SR-4835, sensitizes triple-negative breast cancer cells to PARP inhibitors and DNA-damaging chemotherapeutics by reducing expression of the genes in the DNA damage response pathway.
引用
收藏
页码：461 / 463
页数：4
相关论文
共 50 条
  • [41] Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer
    McArthur, Heather
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 137 - 140
  • [42] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
  • [43] Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
    Cortes, J.
    Rugo, H. S.
    Cescon, D. W.
    Im, S-A
    Yusof, M. M.
    Gallardo, C.
    Lipatov, O.
    Barrios, C. H.
    Perez-Garcia, J.
    Iwata, H.
    Masuda, N.
    Otero, M. Torregroza
    Gokmen, E.
    Loi, S.
    Guo, Z.
    Zhou, X.
    Karantza, V
    Pan, W.
    Schmid, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03): : 217 - 226
  • [44] Pembrolizumab plus chemotherapy in triple-negative breast cancer Reply
    Cortes, Javier
    Rugo, Hope S.
    Guo, Zifang
    Karantza, Vassiliki
    Schmid, Peter
    LANCET, 2021, 398 (10294): : 24 - 25
  • [45] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [46] Therapeutic effects of TOPK inhibitor on triple-negative breast cancer
    Park, Jae-Hyun
    Miyamoto, Takashi
    Matsuo, Yo
    Nakamura, Yusuke
    CANCER RESEARCH, 2015, 75
  • [47] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Heeke, Arielle L.
    Tan, Antoinette R.
    CANCER AND METASTASIS REVIEWS, 2021, 40 (02) : 537 - 547
  • [48] Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
    Arielle L. Heeke
    Antoinette R. Tan
    Cancer and Metastasis Reviews, 2021, 40 : 537 - 547
  • [49] Triple-Negative Breast Cancer
    Winkeljohn, Debra L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
  • [50] Triple-Negative Breast Cancer
    Hudis, Clifford A.
    CANCER JOURNAL, 2010, 16 (01): : 10 - 11
12345